APIS Assay Technologies Ltd.

APIS Assay Technologies Ltd.

生物技术研究

MANCHESTER,UK 3,771 位关注者

We are committed to realise the clinical potential of systems biology in the diagnosis and personalisation of treatment.

关于我们

APIS is leveraging systems biology, interrogating multi-OMICs biodata, and deploying innovative ‘Clickmer’ ligand binding technology, for the validation and translation of biomarker and therapeutic assets into clinical utility. APIS has deep expertise and capabilities in IVD development of molecular & immune assays for ultimate product realisation as diagnostic tests. In addition, APIS' expertise in bioinformatics and software development is offered as an agile service to our clients, to develop bespoke, end-to-end multi-OMICs solutions and platform development. APIS has also developed a broad breast oncology product portfolio: The APIS Breast Cancer Subtyping Kit is a reproducible RT-qPCR based IVD product (in certain territories) and RUO product for detecting standard (HER2, ER, PR, Ki67) and novel proliferative biomarkers. The APIS ESR1 Mutations Kit is a qPCR assay for the sensitive detection of eleven key mutations within the oestrogen receptor gene. Coming soon - the new APIS PIK3CA Mutations Kit is a qPCR assay for the sensitive detection of key mutations in the PIK3CA gene.

网站
https://www.apisassay.com
所属行业
生物技术研究
规模
51-200 人
总部
MANCHESTER,UK
类型
私人持股

地点

APIS Assay Technologies Ltd.员工

动态

相似主页

查看职位